ClinicalThought

Share

Program Content

Activities

  • Belantamab Mafodotin for R/R MM
    My Take on the Recent Approval of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 25, 2020

    Expires: August 24, 2021

  • MM Biochemical Relapse
    Should We Treat Biochemical Relapse in Multiple Myeloma?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 22, 2020

    Expires: September 21, 2021

Faculty

cover img faculity

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Provided by

ProCE Banner

Supporters

GlaxoSmithKline